Изучена эффективность сочетанного применения урсодеоксихолевой кислоты-УДХК
(10 мг/кг/сут) и гептрала (S-аденозилметионин, 800-1600 мг/сут) в лечении 19 больных …

Objective: To report, to our knowledge, the first case of a patient with nodular regenerative
hyperplasia of the liver (NRHL) associated with portal hypertension in whom …

Nutritional management of hepatic diseases is often considered a primary therapeutic
intervention. Manipulation of macronutrients such as protein and fiber plays an integral role …

1. Lirussi F, Beccarello A, Bortolato L et al. Long-term treatment of chronic hepatitis C with
ursodeoxycholic acid: influence of HCV genotypes and severity of liver disease. Liver 1999; …

Background: Drug-induced hepatitis and several features of liver toxicity associated with the
administration of carbamazepine have been reported; they involve non-immunoallergic …

Although suspected hepatopathy in dogs can be assessed by the blood levels of both liver
enzyme activities and functional liver parameters, very often the precise diagnosis of primary …

The dilated cardiomyopathy with ataxia syndrome (DCMA) is a rare autosomal recessive
mitochondrial disease that results from mutations in the poorly characterized DNAJC19 …

SIR, Administration of ursodeoxycholic acid (UDCA) can improve liver function in the course
of several hepatic disorders; in particular, this drug can decrease serum transaminase levels …

Parenteral nutrition (PN) has revolutionized the nutritional care of patients who cannot fully
use the gastrointestinal tract. Today more than 30,000 patients, young and old, depend on …